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1059-23 Selective Activation of Fibrogenetic Growth Factors 
Addresses the Pattern of Hypertrophy in Human Aortic 
Valve Disease 
Pietro A. Modesti, Simone Vanni, llaria Cecioni, Thomas Toscano, Maria Boddi, 
GianGastone Neri Serneri. University of Florence, Florence, Italy 
Backqround. Myocardial fibrosis develops only in some models of hemodynamic over- 
load suggesting the involvement of non-hemodynamic trophic stimuli in the regulation of 
connective tissue growth. The aim of the present study was to investigate cardiac 
expression of fibrogenetic growth factors (GFs) in patients with concentric or eccentric 
myocardial hypertrophy undergoing aortic valve replacement for pure form of aortic 
stenosis (n=16) or regurgitation (n=14). 
Methods. Cardiac platelet derived growth factor (PDGF) and basic fibroblast growth fac- 
tor (bFGF) fomlation was evaluated by measuring gene expression in ventricular biop- 
sies collected at cardiac surgery (RT-PCR) and peptide release in coronary circulation. 
The control group was made of 5 tentative donors, excluded from organ donation for 
noncardiac reasons and 11 subjects with atypical chest pain undergoing diagnostic car- 
diac catheterization. 
Results. In control subjects and in patients with aortic regurgitation PDGF and bFGF car- 
diac gene expression was undetectable and peptide coronary release was negligeable. 
Conversely. in patients with aortic stenosis myocardial expression of mRNAs for PDGF-A 
and -8 chains and for bFGF were all significantly increased as well as the PDGF-AB and 
bFGF release in the coronary circulation (pcO.01 vs controls and vs patients with aortic 
regurgitation for all). In situ hybridization localized growth factor mRNAs in interstitial 
cells. At multivariate stepwise regression analysis the relative wall thickness was 
selected as the most predictive independent variable for PDGF (r=0.72. p<O.Ol) and 
FGF (rcO.62, pcO.01) peptide cardiac release with no significant relationship with indexes 
of cardiac function or afterload mismatch. 
Conclusion. The present results indicate that 1) the gene expression and cardiac forma- 
tion of fibrogenetic GFs are selectively activated only in amtic stenosis with 2) gene 
expression mainly sustained by interstitial cells and 3) stepwise regression analysis 
revealing the significant association between GFs cardiac formation and the pattern of 
hypertrophy. 
1059-24 Patients With Degenerative Aortic Valve Stenoses Have 
Increased Thermal Heterogeneity in the Stenotic Valve 
Konstantinos Toutouzas, Eleftherios Tsiamis, Sophia Vaina, loannis Kallikazaros. 
Konstantinos Tentolouns, Costas Tsioufis, Dimitris Tousoulis. Chris& Pitsavos, Pavlos 
Toutouzas, Christcdoulos Stefanadis , Hippokration Hospital, Athens, Greece 
Background: Inflammation may be involved in the pathogenesis of a&c valve stenosis 
(AVS), possibly leading to local heat release. The aim of our study was to investigate 
whether thermal heterogeneity is present in patients (pts) with and without (AVS) by the 
first human application of an aortic valve thermography catheter. 
Methods: We enrolled 10 pts with AVS undergoing diagnostic catheterization (mean 
age: 74.2 + 8.1 yrs) and 8 pts without AVS (mean age 70.1 + 9.3 yrs) undergoing diag- 
nostic catheterization for the evaluabon of chest pain. An echocardlography was per- 
formed, for the estimation of mean and maximal pressure gradient. Temperature 
measurements were performed by an aortic valve thermography catheter, previously val- 
idated. This 8F thermography catheter has its proximal part attached to a connector with 
a hemostatic valve and to a connector for the thermistor lead-wires. A steering arm 
passes through the hemostatic valve, and through the lumen of the catheter and is 
attached to the tip of the catheter. The distal 20 cm of the shaft of the catheter consist of 
a soft non-thrombotic material and enable this distal part to be curved to 90°C. The ther- 
mistor lead-wires end to the connector and pass through the lumen of the catheter. The 
thermistor probe is positioned at the tip of the catheter. Manipulation of the steering an 
at the proximal end enables the distal end of the catheter to be altered by remote control 
so that the thermistor is in contact with the aortic valve (AV) or aortic wall (AW). Temper- 
ature was measured at different sites of the AV and also on the AW. The maximum differ- 
ence between the temperature of AV and AW was designated as temperature difference 
(TD). 
Results: Temperature measurement of the AV and the AW was successful and uncom- 
plicated. TD was increased in pts with AVS compared to the subjects without AVS (0.54 
+ 0.5 versus 0.05 f. O.Ol”C. p < 0.01). In pts with AVS the mean and maximal pressure 
gradient was not correlated with TD. 
Conclusions: The first human application of an aortic valve thermography catheter was 
successful and uncomplicated. Thermal heterogeneity is frequently found in human aor- 
tic valves in pts with AVS. 
1059-25 Calcified Rheumatic Heart Valves Are Associated With 
Osteopontin Bone Matrix Expression 
Nalinl M. Raiamannan, Trisha Smith, Lisa Nee, Thomas J. Sebo, Raffay Khan, Robert H. 
Bonow. James Fredrickson. David Fullerton, A. Jamil Taiik. Robert 0. Bonow. 
Northwestern University, Chicago, IL, May&Clinic, Rochester. MN 
Introduction: Rheumatic Heart Disease is the most common cause of valvular heart dis- 
ease in developing countries. Despite the high prevalence, the cellular mechanisms are 
not well-defined. We hypothesized that the mechanism for rheumatic valve calcification is 
similar to skeletal bone fonation and that this process is mediated by synthesis of bone 
matrix proteins. TO test this hypothesis, we examined human calcified rheumatic heart 
valves replaced at surgery and normal human valves removed at autopsy. We examined 
light microscopic cellular changes and immunostaining for bone matrix protein expres- 
sion. Methods: Hematoxylin and Eosin (H&E), and Masson trichrome (MT) stains were 
performed. lmmunohistcchemistry was used to localize osteopontin protein, proliferating 
cell nuclear antigen (PCNA) and alpha actin (AA). Quantification of PCNA was done 
using a CAS 200 image analyzer (Baccus Labs, Inc; Lombard, IL) and expressed as the 
percent of nuclear area staining. Osteopontin immunostaining was evaluated from rheu- 
matic heart valves (N=22), and normal valves (N= 22). Results: H&E and MT stains con- 
firmed the presence of dense mineralization in the calcified rheumatic heart valves, a 
finding that was absent in the normal valves. lmmunohistochemistry localized osteopon- 
tin and alpha actin to areas of calcification in all of the cardiac valves. PCNA expression 
was positive in 5 of 22 rheumatic cardiac valves. The mean level of PCNA expression 
was (37.64 f 13.59) compared with normal valves (1.26 f 0.32). Conclusions: These 
results indicate that osteopontin producing cells are involved in an active process of cal- 
cification and support the idea that rheumatic valve calcification is not a random, passive, 
degenerative process. Rather, it is a regulated cellular process associated with the 
expression of bone matrix protein important in skeletal bone formation. 
1059-26 lnterleukin 1 Beta Induces Matrix Metalloproteinase 
Expression in Human Aortic Valve Myofibroblasts In 
Vitro and Promotes Cell Proliferation 
Jens J. Kaden. Refika Kilic, Aslihan Sankoc, Karl K. Haase, Carl-Erik Dempfle, Martin 
Borggrefe, University Hospital Mannheim, Mannheim, Germany 
Background: Recent studies suggest that calcific aoriic stenosis, the most prevalent 
heart valve disease in the elderly, may be based on a chronic inflammatory process 
involving invasion and activation of leukocytes. We have shown recently that the pro- 
inflammatory cytokine tumor necrosis factor alpha is upregulated in stenotic aortic 
valves, and that it is associated with the remodeling of the extracellular matrix. The role 
of the pro-inflammatory cytokine interleukin 1 beta (IL-lb) on the pathogenesis of calcific 
aortic stenosis is unknown. 
Methods: Human aoltic valve myofibroblasts were isolated from explanted aortic valves 
and grown in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf 
serum, penicillin, streptomycin and fungizone. After 24 hours of serum-free culture, sub- 
confluent cells were incubated with or without IL-lb (10 nglmL) for various durations. 
Western blotting for MMP-1 and gelatin zymography for MMP-2 and MMP-9 were per- 
formed with conditioned media. Cell proliferation with or without IL-1 b at various concen- 
trations was assessed by bromodesoxyuridine uptake assay. 
Results: Incubation with IL-1 b lead to a significant, time-dependent increase in MMP-1, 
MMP-2, and MMP-9 in conditioned cell culture media as compared to control. Cell prolif- 
eration was increased 3.6-fold as compared to control on incubation with IL-1 b at a con- 
centration of 0.1 ng/ml (PcO.05). 
Conclusion: IL-lb induces MMP expression in human aorlic valve myofibroblasts in 
vitro and promotes cell proliferation. These results suggest that matrix remodeling in cal- 
cific aortrc stenosis may be actively regulated, involving an inflammatory process. This 
could could be a potential therapeutic target for calcific aortic stenosis. 
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1084-21 Echocardiographic Classification of lschemic Mitral 
Regurgitation Based on Mitral Leaflet Motion, Left 
Ventricular Remodeling, and Characteristics of the 
Regurgitant Jet 
Eustachio Aqricola, Michele Oppizzi, Francesco Maisano, Michele De Bonis, Lucia 
Torracca, Giovanni La Canna, Ottawa Alfieri. Ospedale San Raffaele. Milano, Italy 
Background: Although the mechanism of ischemic mitral regurgitation (MR) are under- 
stood, its echocardiographic picture is not homogeneous. We hypothesized the exist- 
ence of different echocardiographic subgroups of patients with chronic ischemic MR 
focusing the attention on mitral leaflets motion, lefl ventricular (LV) remodeling and char- 
acteristics of the regurgitant jet. 
Methods: Seventy-four consecutive patients (mean age 64210.7 years) with chronic 
ischemic MR. were divided in two groups by transthoracic echocardiography on the basis 
of mitral leaflets motion: the asymmetric makoaptation group with tethering only of the 
posterior leaflet (45 patients) and the symmetric one with tethering of both leaflets (29 
patients). The LV global [(volumes, ejection fraction (EF) and systolic short-to-long-axis 
dimension ratio (D/L)] and local (papillary muscle displacements and regional wall motion 
score index) remodeling were evaluated. Transesophageal echocardiography (TEE) was 
performed to better study the characteristics of the MRResults: All indexes of global LV 
remodeling were significantly higher in the symmetric than asymmetric group (end dias- 
tolic and systolic volumes: 23592 vs 198+20 ml, 158119 vs 108_+15 ml, EF%:29.7+7 vs 
44.4+9.5, D/L: 0.88fl.10 vs 0.59+0.06, all p<O.OOOl) such as the posterior (3.kO.6 vs 
2.720.7 cm, ~~0.04) and lateral displacement (2.5tO.5 vs 2fl.5 cm. ~~0.04) of the ante- 
rior papillary muscle, the papillary muscle separation (4+0.6 vs 3.120.7 cm, p<O.OOOl) 
and the anterior papillary muscle wall motion Index (1.70.6 vs 1 .1+0.3, p<O.OOOl). The 
TEE showed that the origin as well as the direction of the jet was central in all patients of 
the symmetric group. In the asymmetric one the origin was central in 77% of cases and 
arising from the medial commissure in 23% whereas the jet direction was posterior and 
central in 81% and 19% of patients respectively. 
Conclusion: It is possible to distinguish at least two subgroups of patients with ischemic 
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MR with different degree of local and global LV remodeling. and characteristics of the 
regurgitant jet. Such, a complete characterization of the pattern of ischemic MR could aid 
to tailor the best treatment for the single patient 
1084-22 Papillary Muscle Dysfunction Attenuates lschemic 
Mitral Regurgitation in Patients With Localized Basal 
Inferior Left Ventricular Remodeling 
Takeshi Uemura, Yutaka Otsuji, Toshiro Kumanohoso, Kunitsugu Takasaki, Toshinon 
Yuasa, Woo-Shik Kim, Akira Klsanuki, Shinichi Minagoe, Robert A. Levine, Chuwa Tei, 
Kagoshima University, Kagoshima, Japan, Massachusetts General Hospital, Boston, MA 
Background: In principle, papillary muscle (PM) dysfunction could be associated with 
less mitral regurgitation (MR) because of PM elongation, attenuating tethering. However, 
variability in the degree of left ventricular (LV) remodeling can influence the relation 
between PM dysfunction and MR. We. therefore, hypothesized that PM dysfunction 
attenuates MR in patients with comparable degree of segmental basal inferior LV remcd- 
cling. 
Method: From 38 consecutive patients with previous inferior myocardial infarction. 2 
patients with global LV remodeling and 12 with only modest inferior remodeling were 
excluded. In the remaining 24 patients with significant and localized basal inferior LV 
remodeling, LV volume, mitral annular area, PM tethering distance, % systolic thickening 
of middle p&ion of medial PM and MR fraction were quantified by 2.dimensional and 
Doppler echocardiography. 
Results: % systolic PM thickening had positive and significant relation with % MR fraction 
(figure), which was best correlated with medial PM tethering distance. 
Conclusion: lschemic MR can be attenuated by PM dysfunction, reducing leaflet tether- 
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1084-23 Inhibition of the cJun N-Terminal Kinase Pathway 
Minimizes Collagen Remodeling in Aortic Regurgitant 
Hearts 
Eungsuk Lee, Sharada L. Truter, Lisa Pitlor, Zhen Huang. Anuj Gupta, Jeffrey S. Borer, 
Weill Medical College, Cornell Unwersity, New York, NY 
Background: Fibrosis associated with aortic regurgitatton (AR) shows abnormal 
fibronectin (FN) but normal collagen content. This pathologic fibrosis is important in gen- 
esis of heart failure (CHF) in AR; understanding fibrosis generation may enable specific 
therapy to retard CHF. We showed that increased FN expression by cardiac fibroblasts 
(CF) from rabbits with catheter-induced AR results from activation of the c-Jun N-terminal 
kinase (JNK) pathway, which also can upregulate collagen-specific metalloproteases 
(MMPs). To see if JNK activation of MMP is involved in minimizing collagen content in 
AR we assessed MMP-2 activity with SP600125, a specific JNK inhibitor. Methods: NL- 
CF vs AR-CF (3 pairs) from rabbits were grown in triplicate with and without 2Ofl 
SP600125. Media then were collected for 24 hr intervals wer 5 days. Enzymes were 
separated by gelatin-containing zymograms, stained with coomassie blue, destained, 
and analyzed by videodensitometry. Band intensities were normalized to total cell protein 
concentrations. Results: MMP-2 activity was upregulated in AR-CF vs NL-CF 
(AR:NL=2.1:1. p< .03). When CF were grown with SP600125, MMP-2 activity was maxi- 
mally downregulated by day 2 vs day 0 (NL, 1.0:0.4, p< ,001; AR, 1.0:0.5. p< ,001. 
Table). Conclusion In AR myocardium, fibrotic myocardium featuring abnormal FN but 
normal collagen content results in part from AR-Induced upregulation of MMP-2 by JNK 
stimulation. Inhibition of this reaction may help mitigate pathologic fibrosis and CHF. 
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1 2 3 4 5 
Exposure Day(N) + 
Cell Line J 
NLl 1:0.4 1:0.5 1:0.7 
NL2 1:O.E 1:0.3 1:0.6 
NL3 1:0.7 t :0.3 1:0.4 
Average 1:0.6 1:0.4 1:0.5 
AR1 1:0.5 1:0.2 1:0.5 
AR2 1:o.g 1:0.6 1:0.7 
AR3 1:o.g 1:0.2 1:0.4 
Average 1:O.B 1:0.5 1:0.6 

















1084-24 Heterogeneity of Response to Pressure Overload in 
Aortic Stenosis 
Danita M. Yoeraer, Marcia B. Leavitt, Michael H. Picard, Massachusetts General 
Hospital, Harvard Medical School, Boston, MA 
Left ventricular hypertrophy IS a ccmmcn response to the pressure overload conditions of 
acttic stenosis. The precise nature of this relationship, however has yet to be elucidated. 
Methods: We identified 265 patients referred for routine transthoracic echocardiography 
in the past 9 months who were found to have aortic stenosis with an aortic valve area 
<l .O cn? and normal regional wall motion. Patients were excluded if they had LV cavity 
dilatation suggestive of eccentric hypeltrophy (n=99) or inadequate echocardiography to 
perform the analysis(n=lO). We assessed septal wall thickness(lVS), posterior wall thick- 
ness (PWT), chamber dimensions, ejection fraction, aortic gradients, aortic valve area, 
and calculated left ventricular mass. Correlation coefficients were calculated to examine 
the relationship between wall thicknesses and peak pressure gradients(PKGR). Results: 
Of the 175 patients included in this analysis, 49% were men, and the mean age was 74 
+I- 0.9 years. While significant correlation coefficients were demonstrated for the rela- 
tionship between IVS and PKGR (R=0.27, p<O.O003), between PWT and PKGR 
(R=0.30, p<O.OOOl), and between LV mass and PKGR (R=O.26, P<O.O005), a large per- 
centage of patients failed to demonstrate hypedrophy at significant pressure gradients 
(Fig 1). Conclusion: The hypertrophic response to pressure overload in aortic stenosis 
appears heterogeneous. Other factors which influence ventricular remodeling may play a 
role in this process. 
1084-25 Effect of Candesartan Cilexetil on Left Ventricular 
Remodeling in Mitral Regurgitation: A Randomized 
Clinical Trial 
Maurice L. Enriquez-Sarano, Michael Bellamy, Jean-Francois Avierinos David L. (- 
Messika-Zeitouq Vuysile Nkomo. Mayo Clinic, Rochester, MN 
Background:The effect of tissue angiotensin blockade in Mitral Regurgitation (MR) due 
to intrinsic valve disease is disputed due to lack of randomized clinical trials. Of particular 
importance is the effect of these medications on left ventricular (LV) remodeling, ie.. on 
LV end-diastolic and end-systolic volume index (EDVI, ESVI). Candesartan Cilexetil is an 
anglotensin receptor blocker with insurmountable receptor attachment allowing prc- 
longed clinical efficacy. 
Methods: In 32 patients (age 69+14 years, 36% female) with organic MR of at least 
moderate degree, in functional Class I or II, with normal renal function (creatinine 1.1+0.2 
mg/dL), patients were randomized between placebo (n=l7) or Candesartan Cilexetil 32 
mg/daily (n=l5) treatment for 1 year. After one year the end-points of EOVI and ESVI 
were measured. 
Results:At baseline, there was no difference between placebo and Candesartan groups 
forage, sex. systolic (141*19 vs. 144i18 mmHg, P=O.69) and diastolic (74+10 vs. 77+14 
mmHg, P=O.46) blood pressure, regurgitant volume measured by 2 methods (73*25 vs. 
77*14 ml/beat, P=O.97), EDVI (103221 vs. 104+19 mUm2,) and ESVI (26+9 vs. 25tlO 
